PVLA
Financials
- Market Capitalization 2.16 B
- Employee 29
- Founded N/A
- CEO N/A
- Website www.palvellatx.com
- Headquarter Nevada, United States
- FIGI BBG0055C3N57
- Industry Drug Manufacturers—General
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1716 |  MBX MBX Biosciences, Inc. - Common Stock | 63.00 USD | -5.11% | -4.88% | -2.84% | +321.69% | 3.03 B USD | ||
| 1896 |  RAPP Rapport Therapeutics, Inc. - Common Stock | 48.77 USD | -4.05% | +1.27% | +16.98% | +86.22% | 2.34 B USD | ||
| 2021 |  GENB Generate Biomedicines, Inc. - Common Stock | 15.33 USD | -2.79% | -8.53% | +16.93% | +2.20% | 1.97 B USD | ||
| 2181 |  MAZE Maze Therapeutics, Inc. - Common Stock | 27.44 USD | -4.06% | -6.25% | -0.11% | -39.06% | 1.52 B USD |
Frequently asked questions about Palvella Therapeutics, Inc. Common Stock
What is the Palvella Therapeutics, Inc. Common Stock stock price today?
The current price of Palvella Therapeutics, Inc. Common Stock (PVLA) is 149.97. Over the past 24 hours, the stock has changed by -0.24%. Follow the PVLA chart for real-time price dynamics.
What is the stock ticker of Palvella Therapeutics, Inc. Common Stock?
Palvella Therapeutics, Inc. Common Stock trades under the ticker PVLA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Palvella Therapeutics, Inc. Common Stock stock going up?
PVLA has changed by +7.11% over the last week, +3.79% over the last month, and +103.07% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Palvella Therapeutics, Inc. Common Stock?
Palvella Therapeutics, Inc. Common Stock currently has a market capitalization of 2.16 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Palvella Therapeutics, Inc. Common Stock earnings last quarter?
Last quarter, Palvella Therapeutics, Inc. Common Stock reported earnings of -1.52 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Palvella Therapeutics, Inc. Common Stock revenue for the last quarter?
Palvella Therapeutics, Inc. Common Stock reported quarterly revenue of 1.97 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Palvella Therapeutics, Inc. Common Stock net income for the last quarter?
Palvella Therapeutics, Inc. Common Stock reported net income of -21.87 M for the last quarter. The previous quarter showed -15.77 M, which means net income changed by -38.71%.
How many employees does Palvella Therapeutics, Inc. Common Stock have?
As of the latest available data, Palvella Therapeutics, Inc. Common Stock has 29 employees. Workforce size can provide additional context about the company's scale and operations.
What is Palvella Therapeutics, Inc. Common Stock EBITDA?
Palvella Therapeutics, Inc. Common Stock EBITDA is -19.76 M, and its EBITDA margin is -1 005.6%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Palvella Therapeutics, Inc. Common Stock stock?
You can buy Palvella Therapeutics, Inc. Common Stock (PVLA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Palvella Therapeutics, Inc. Common Stock stock?
Investing in Palvella Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the PVLA chart and related analysis on metatrader.com as part of your research.